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Abstract
Antimicrobial resistance (AMR) is a growing threat to global public health, and
the overuse of antibiotics in animals has been identified as a major risk factor.
With high levels of international trade and direct connectivity to the aquatic envi-
ronment, shrimp aquaculture may play a role in global AMR dissemination. The
vast majority of shrimp production occurs in low- and middle-income countries,
where antibiotic quality and usage is widely unregulated, and where the integra-
tion of aquaculture with family livelihoods offers many opportunities for human,
animal and environmental bacteria to come into close contact. Furthermore, in
shrimp growing areas, untreated waste is often directly eliminated into local water
sources. These risks are very different to many other major internationally-traded
aquaculture commodities, such as salmon, which is produced in higher income
countries where there are greater levels of regulation and well-established manage-
ment practices. Assessing the true scale of the risk of AMR dissemination in the
shrimp industry is a considerable challenge, not least because obtaining reliable
data on antibiotic usage is very difficult. Combating the risks associated with
AMR dissemination is also challenging due to the increasing trend towards inten-
sification and its associated disease burden, and because many farmers currently
have no alternatives to antibiotics for preventing crop failure. In this review, we
critically assess the potential risks the shrimp industry poses to AMR dissemina-
tion. We also discuss some of the possible risk mitigation strategies that could be
considered by the shrimp industry as it strives for a more sustainable future in
production.
Key words: antibiotics, antimicrobial resistance, aquaculture, international trade, low and middle
income countries, shrimp.
Introduction
Antimicrobial resistance (AMR) is the term used to
describe microbial organisms that can resist the effects of
drugs and chemicals designed to kill them. It is now widely
regarded one of the greatest risks to human and animal
health, and the current rate of spread is such that by 2050
an estimated 10 million people globally will die from resis-
tant infections, with an associated economic cost of £60
trillion (O’Neill 2016). For many years, research into AMR
was principally focused on human health, but more
recently, much interest has been directed to the agricultural
and environmental sectors, due to the intrinsic interlink-
ages between humans, animals and the environment (the
‘One Health’ notion). Furthermore, almost 70% of total
antibiotic use is in livestock and this consumption is pro-
jected to rise by 67% by 2030 (Van Boeckel et al. 2015).
This is a major concern since the overuse of antibiotics has
been identified as the single most important factor driving
the rise in resistant infections (CDC, 2013). Although
antibiotic usage in humans in high-income countries
appears to be gradually reducing (Klein et al. 2018), it
© 2019 The Authors. Reviews in Aquaculture Published by John Wiley & Sons Australia, Ltd 1
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Reviews in Aquaculture, 1–21 doi: 10.1111/raq.12367
remains high in some food production sectors, most nota-
bly poultry and swine (Van Boeckel et al. 2015). In low and
middle income countries (LMICs), antibiotic consumption
in both humans and animals is increasing (Van Boeckel
et al. 2015; Klein et al. 2018), although precise data is often
difficult to obtain since usage is widely unregulated and
indiscriminate, with antibiotics freely available ‘over the
counter’ and little capacity for enforcing regulations and
surveillance. Controlling contagion, through improving
sanitation, access to clean water and governance, has also
been shown as key to controlling AMR dissemination (Col-
lignon et al. 2018), and since these factors are frequently
associated with LMICs, this further emphasizes the signifi-
cant risks of antibiotic usage in animal production in these
countries.
Aquaculture (the farming of aquatic organisms) is con-
sidered one of the most sustainable sources of animal pro-
tein and is the fastest growing food sector, yet in order to
meet global demand, production must further expand by
50% by 2050 (FAO, 2014). Currently, aquaculture accounts
for around 10% of all animal protein consumed globally,
with this figure expected to increase by 50% by 2030 (The
World Bank, 2013). In 2016, 93% of aquaculture produc-
tion took place in LMICs (89% in Asia; FAO, 2016a), and
although much of the produce is consumed domestically,
there is a huge international export market. As in agricul-
ture, aquaculture is thought to have high levels of antibiotic
use, although exact figures for much of the industry are
hard to confidently establish due to the lack of surveillance.
In terms of risk to AMR dissemination, aquaculture is of
particular concern in terms of the propensity for emer-
gence, persistence and transmission within the aqueous
environment, which is already known to be an important
reservoir of clinically relevant antimicrobial resistance
genes (Marti et al. 2014). In addition, the relative lack of
infrastructure in terms of waste treatment in many LMICs
means that any treatments (including antibiotics) and
microbial matter (including resistant bacteria) from ponds
are often released directly into the aquatic environment.
Transmission to people may also be enhanced through
direct contact with pond water and livestock; an estimated
18 million people work within the primary aquaculture
industry globally (FAO, 2016b). Despite these significant
risk factors, aquaculture has thus far received relatively little
attention in terms of infectious disease and AMR research.
In this review, we evaluate current understanding of the
role of the shrimp aquaculture industry in the emergence
and dissemination of AMR. Many other forms of aquacul-
ture, notably finfish, share many of the same risks for AMR
(Henriksson et al. 2017), but we focus on shrimp aquacul-
ture (used collectively to refer to the farming of shrimp and
prawn species) for the following reasons. Firstly, shrimp
has a large, growing, global market and is traded extensively
around the world. Secondly, the farming of crustaceans
brings somewhat different risks and challenges compared
to fish species, which in the context of AMR mainly relates
to the fact that shrimp do not have an acquired immune
system and can therefore be more susceptible to pathogens,
often leading to a greater need for antimicrobial treatments
(Smith et al. 2003; Hauton & Smith 2007). Thirdly, the
more primitive immune system in shrimp does not
respond to vaccination, which in the fin fish industry has
paid great dividends in terms of reducing disease and
antimicrobial usage (Sommerset et al. 2005; Gudding &
Van Muiswinkel 2013). Finally, most shrimp production
(87% in 2016) occurs in Asia (FAO, 2016a) and this is an
area that has been identified as posing a very significant risk
to the global burden of AMR (Chereau et al. 2017). In this
review, we assess the existing evidence for the emergence
and dissemination of AMR in this sector, and review the
drivers behind antimicrobial use in shrimp aquaculture
worldwide. We also discuss possible risk mitigation strate-
gies, aimed at promoting the prudent use of antibiotics
and/or reducing the necessity for them, in order to increase
the sustainability of the shrimp industry and minimize its
contribution to the growing global AMR problem.
The global shrimp industry
In 2016, 67% of global shrimp production was farmed and
33% wild-captured (FAO, 2016a). Marine shrimp farming
makes up the vast majority of production, and mainly
involves two penaeid shrimp species, Penaeus vannamei
(Whiteleg shrimp) and Penaeus monodon (Giant tiger
prawn). The shrimp industry began to develop on a large
scale in coastal areas of South East Asia in the 1970s, and
although Peneaus monodon was the preferred species for
many years, its susceptibility to disease has led to a prefer-
ence for farming Litopenaeus vannamei, which has consti-
tuted the largest shrimp industry growth. Freshwater prawn
farming has also been gradually increasing, and here the
two main species are Macrobrachium rosenbergii (Giant
river prawn) Macrobrachium nipponense (Oriental river
prawn; Fig. S1). Shrimp farming has been a traditional way
of life for many years, through trapping larvae from rivers
or seas and cultivating them. A large proportion of shrimp
farmers across the globe remain as small holders, with
extensive pond systems (large ponds, with low animal den-
sities), and shrimp farming is often integrated with other
types of crops and livestock production, with a view to
making the most efficient usage of the land and minimising
the economic risks associated with monoculture and dis-
ease (Fig. 1). However, in many established shrimp-pro-
ducing countries, including Thailand, Vietnam and China,
intensive shrimp farming is increasing. In many cases, this
includes the use of enclosed recirculating aquaculture
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systems (RAS) as they require less water and have improved
biosecurity in order to reduce disease risk. Intensification
of shrimp production has largely been possible due to the
adoption of new technologies, such as improved feed for-
mulations and the hatchery production of specific patho-
gen-free (SPF) post-larvae from breeding adults
(broodstock; Kumar & Engle 2016). Broodstock are typi-
cally obtained from the wild but a reduction in numbers
and increased prevalence of disease in wild stock has led to
the development of broodstock domestication in some
countries, which commonly offer SPF animals (mainly
Litopenaeus vannamei) that are certified as free from a
number of common diseases.
One of the main disadvantages of captive broodstock
breeding programmes is that, without very careful manage-
ment, a reduced genetic diversity can result, increasing the
risks associated with disease susceptibility. Disease is a sig-
nificant constraint on the development and sustainability
of shrimp and prawn culture and has had devastating
impacts on entire geographical regions of the industry.
Shrimp are affected by a range of bacterial, viral, fungal and
parasitic pathogens and until recently the highest profile
problems have been caused by viral diseases, notably White
Spot Syndrome Virus (WSSV); cumulative losses to this
pathogen alone were estimated in 2012 to be more than
USD 6 billion (Lightner et al. 2012). Bacterial diseases are
also a major problem. For example, it is now recognized
that acute hepatopancreatic necrosis disease (AHPND), is
associated with strains of bacterial Vibrio species carrying
an insect toxin plasmid (Han et al. 2015; Restrepo et al.
2018). Infections cause up to 100% mortality in post-larvae
shrimp, and losses due to this pathogen were estimated at
more than USD 1 billion in Asia at the end of 2013 (FAO,
2013). This increasing disease burden not only threatens
the national GDP of these LMICs but also has a huge
impact on the livelihoods of those who depend on subsis-
tence farming. To illustrate this, an infection in Vietnam in
2006 resulted in the death of 50% of the 2 billion shrimp
post-larvae cultivated, and this affected an estimated 14,000
households (Anh et al. 2010).
Figure 1 Shrimp farming. Typical shrimp farming process, showing characteristics of the different types of production: intensive, extensive and inte-
grated. Images are of ponds in Bangladesh (credits shown).
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Despite the high disease burden, shrimp was the most
highly traded food commodity by value for many years,
until it was overtaken in 2016 by salmon (Fig. 2a). In
this year, these two products alone represented 32.5% of
the aquaculture export industry (USD 23.5 billion exports
for salmon and USD 22.9 billion for shrimp; FAO,
2016a). Although the international market value of these
commodities is very similar, the nature of these industries
differs greatly. Salmon are exported and traded between
high-income countries (HICs), whereas the majority of
shrimp production takes place in LMICs and is exported
to HICs (Figs 2b and S2). The growth of both the shrimp
and salmon industries has been largely supported by the
intensification of production, however, the increased
levels of disease associated with this intensification has
placed an ever-growing importance on the containment
of both known and emerging pathogens. Between 1987
and 2013, the Norwegian aquaculture industry (which is
predominantly salmon production) increased from
300,000 tonnes to 1.2 million tonnes; the use of vaccina-
tion against major pathogens and the availability of water
of high quality is considered to have supported the con-
tainment of the disease through this intensification, since
antibiotic use was reduced by 99% during this same per-
iod (Norwegian Ministry of Health and Care Services,
2015). In contrast, the reduction in the rate of growth of
the shrimp industry is largely due to problems with dis-
ease, and antimicrobial agents (e.g. disinfectants, fungi-
cides) have become an integral part of many shrimp
farming-operating procedures. Improved water quality,
better hygiene and stricter farm biosecurity measures
would undoubtedly go a long way to addressing the
problems with disease in shrimp production, and there-
fore reduce the need for antibiotic usage. Levels of sanita-
tion infrastructure and governance in the main shrimp-
producing countries are also very low (Figs 3a–c and S3),
and, without the option of vaccination, there is limited
scope for prophylaxis. Due to the nature of shrimp farm-
ing, most shrimp-producing countries also have a warmer
climate that lends itself to greater pathogenic burden and
an increased number of vectors such as insects and
migratory birds, which have been shown to play an
important role in both disease and AMR dissemination
(Fig. 3d; Ahlstrom et al. 2018; Onwugamba et al. 2018).
Antibiotic usage in shrimp aquaculture
A wide range of antibiotics and other antimicrobials,
including heavy metals, fungicides and antiparasitics, are
used in shrimp aquaculture, with many reports describing
Salmon
Shrimp
(a)
(b)
Figure 2 The global shrimp industry. (a)
Shrimp and salmon are the highest interna-
tionally-traded seafood commodities by value.
In 2016, salmon overtook shrimp as the high-
est value traded commodity. Data, obtained
from the FAO’s FishStat J Global Fishery and
Aquaculture Commodity Statistics Dataset,
shows the total global market value of exports
over time. (b) Weighted average GDP per cap-
ita of the top 10 shrimp and salmon exporting
and importing countries. Weighted averages
were calculated by taking the sum of
imports/exports (data from the FAO’s FishStat
J Global Fishery and Aquaculture Commodity
Statistics Dataset) for the top 10 countries and
calculating each country’s fraction of this. This
fraction was then multiplied by the GDP per
capita for that country (World Bank databank;
2015 data) to obtain the weighted average
score. Total aquaculture (green); Shrimp (red);
Salmon (blue).
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the use of clinically relevant antibiotics, particularly in
hatcheries (Holmstrom et al. 2003; Uddin & Kader 2006;
Thuy et al. 2011; Mostafa Shamsuzzaman & Kumar Biswas
2012; Ali et al. 2016; Chi et al. 2017; Hinchliffe et al. 2018).
However, as is the case in most LMICs, accurate antimicro-
bial sales and usage data are difficult to obtain since antibi-
otics are freely available over the counter without a
veterinary prescription, and can be of varying quality (Tran
et al. 2018). Many shrimp farmers do not have easy access
to professionals or facilities for accurate disease diagnosis,
and obtain advice on treatments from farm supply shops,
neighbouring farmers, government representatives, non-
governmental organizations such as Worldfish (https://
www.worldfishcenter.org/) or drug manufacturers/vendors,
who are also known to provide financial incentives (Pham
et al. 2015). Collating information on antibiotic sales and
usage is also difficult, due to considerable differences
between farm types, sizes, species, climate, geography, dis-
ease risk, water supply, etc., even within one country. Fur-
ther, antibiotic usage may fluctuate greatly from year to
year, even in the same regions, due to climate and disease
outbreaks. This high level of variation in antibiotic usage is
reflected in inconsistent reports from farmer surveys (Lyle-
Fritch et al. 2006; Thuy et al. 2011; Rico et al. 2013;
Tusevljak et al. 2013; Ali et al. 2016; Liu et al. 2017; Thi
Kim Chi et al. 2017), and this situation is familiar across
the aquaculture world, with reviews on antibiotic usage in
general aquaculture demonstrating the scale and
Governance
Sanitaon 
infrastructure
Average 
temperature
(a)
(b)
(c)
(d)
Figure 3 Selected comparisons between the
top 10 shrimp and salmon producing coun-
tries. (a) Global geographical distributions of
the top 10 shrimp (red) and salmon (blue) pro-
ducing countries. Data obtained from the
FAO’s FishStat J Global Fishery and Aquacul-
ture Production Statistics Dataset were used to
produce the map with www.mapchart.net.
(b–d) Differences between shrimp (red) and
salmon (blue) producing countries in terms of
(b) governance (taken as mean Regulatory
Quality Score in 2017; regulatory quality is one
of the six dimensions of governance used in
the World Governance Indicators Project:
http://info.worldbank.org/governance/WGI/
#home), (c) sanitation infrastructure (World
Bank Databank 2015 data: People using at
least basic sanitation services (% of popula-
tion)) and (d) climate: average monthly tem-
perature between 1991–2015 (World Bank
Climate Change Knowledge Portal).
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complexity of this issue (Vignesh et al. 2011; Done et al.
2016; Muziasari et al. 2016; Mo et al. 2017; Lozano et al.
2018).
Antibiotics are typically applied by mixing with feed or,
less commonly, directly to the water. The direct application
of antibiotics only to the individual animals requiring treat-
ment (therapy) is not practical, so treatments are typically
considered to be metaphylactic (where the whole popula-
tion of animals, including both infected and uninfected
animals are treated). True prophylactic use in aquaculture,
where the animals are treated in the absence of disease, is
considered rare in farms but more common in hatcheries
(Smith 2008, 2012; Zhang et al. 2011). A recent study on
Bangladesh shrimp hatcheries reported the use of up to
80 kg antibiotics per production cycle in a single hatchery
(Hinchliffe et al. 2018).
The limited scope for immunoprophylaxis results in
antibiotics currently being the most common method for
preventing and treating disease in shrimp aquaculture,
despite many of the most devastating diseases in recent
years having been viral. Thus, although we cannot estimate
the potential losses saved by the use of antimicrobials,
antibiotic usage in shrimp aquaculture is likely to be inap-
propriate and inefficient, due to limited diagnostic capac-
ity, poor regulation of quality and usage and poor
application (in terms of antibiotic selection, doses, meth-
ods, timing, etc.). Generally, antibiotic usage (and antimi-
crobial use more widely) is thought to be higher in
intensive rearing systems where there is a greater need for
chemical agents to clean and maintain shrimp pond
hygiene, as well as to prevent or treat disease.
Antimicrobial resistance in the shrimp industry
The ability of AMR genes to pass between bacteria, a pro-
cess known as horizontal gene transfer, or HGT, is thought
to underlie the rapid rise in resistant pathogens seen across
the globe (Martinez et al. 2015). This process can occur
between unrelated bacterial species (Li et al. 2018), mean-
ing that resistance genes (which confer antibiotic resistance
to the bacteria carrying them) present in non-pathogenic,
environmental bacteria (many species of which are uniden-
tified) can be transferred to animal or human pathogenic
bacteria and pose a threat to animal and human health.
This risk is most likely to occur in environments where
non-pathogenic and pathogenic bacteria are brought into
close contact, such as animal/human guts and environ-
ments where animal/human waste is present, such as waste
water treatment plants, agricultural soils and in surface
water run-off from land applied with organic fertilization.
Resistance gene dissemination is further exacerbated by the
presence of antimicrobial compounds, which select for the
expression and transfer of resistance genes, even at low
concentrations (Wistrand-Yuen et al. 2018). There is evi-
dence to support the transfer of AMR genes from clinically
relevant pathogens to aquatic organisms, with studies
demonstrating that fish and shellfish pathogens have
acquired resistance genes within mobile genetic elements
(MGEs; segments of DNA that are easily transferred from
one bacterium to another, e.g. transposons and plasmids)
with very high similarity to those previously recovered
from clinical bacterial isolates, demonstrating likely shared
recent origins (McIntosh et al. 2008). An increasing num-
ber of publications have described the genetic basis of AMR
in aquaculture environments, and a comprehensive review
on this subject has been recently published (see Miller &
Harbottle, 2018). Thus, the presence of resistance genes in
MGEs in fish pathogens (including zoonotic pathogens)
demonstrates the potential for AMR dissemination to ani-
mal/human/environmental bacteria through HGT.
Considering the size and international nature of the
shrimp industry, there is very little information on AMR in
shrimp farming environments. This is surprising as these
farms are potential AMR dissemination hotspots for many
reasons: stocking densities are often very high, which brings
with it associated high bacterial densities and raised stress
levels for shrimp, which in turn makes the stock more sus-
ceptible to infection; high levels of disease incidence; the
widespread usage of chemicals; the release of untreated
waste into the local environment; and high levels of unpro-
tected human contact with water/animals. The large quan-
tities of shrimp that are then transported and consumed
both domestically and internationally make it likely that
this industry poses a significant risk to global AMR dissem-
ination (Fig. 4). Although many of these risk factors can be
applied to a large proportion of the aquaculture industry in
general, one of the AMR risks that is particularly pertinent
to shrimp farming is the high level of traditional integrated
farming practices, where human and livestock/poultry
waste is used to fertilize ponds in order to promote algal
growth within the pond which the shrimp then feed on.
This is not only common but also promoted by many gov-
ernments as being more environmentally and economically
sustainable, however it increases the prevalence of human
and zoonotic pathogens in the shrimp pond. Furthermore,
the heavy use of antibiotics in livestock and poultry
increases the levels and variety of antibiotic residues present
in the pond, increasing the selection pressure. In these
farming systems, sludge (sediment) from ponds is often
used to feed the animals or fertilize vegetable or rice fields,
which are subsequently also used for human and animal
consumption. Thus, an environment is created which
favours the emergence and spread of AMR genes, and this
is supported by reports identifying high levels of resistance
in these systems (Suzuki & Hoa 2012). Indeed, in one study
in an integrated fish farming, it was shown that there was a
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significant increase in resistance across a crop cycle, from
levels of 1–5% of bacteria to 80–100% in 2 months, and
particularly high levels of resistance in human-associated
Enterococcus bacteria (Petersen et al. 2002).
The impact of resistant infections on shrimp health is
largely unknown, since few farmers have access to diagnos-
tic services to identify the pathogen causing the disease,
let alone the resistance levels. In 1994, mass mortality of
shrimp larvae due to antimicrobial resistance was reported
in Indian hatcheries, where 70–90% of larvae died from
infection with strains of Vibrio harveyi that were highly
resistant to a number of drugs, two of which (cotrimoxa-
zole and chloramphenicol) had been used prophylactically.
The lack of resistant Vibrio in the input sea water and
shrimp eggs led the authors to conclude that the long-term
use of these drugs had led to a build-up of resistant bacteria
in the larval rearing tanks (Karunasagar et al. 1994). This
was also supported by a separate study by the same
researchers, who tested water samples from six hatcheries
in India and found that larval tanks were predominantly
populated by Vibrio species, with very high levels of resis-
tance to many different antibiotics (Otta et al. 2001).
With the tripartite agreement from the WHO, FAO and
OIE focused on addressing the problem of AMR on a global
scale, there is an increasing drive towards better regulation
of antimicrobial usage. In line with this, all of the top 10
shrimp-producing countries had AMR action plans under
development as of July 2018, according to the WHO AMR
self-assessment survey, which has set out to collect data
from each country annually in order to monitor and evalu-
ate the global AMR action plan (Fig. 5). Implementation of
these action plans is, however, more of a challenge, and
progress towards this is far less advanced (Table S1). When
compared to the salmon industry, shrimp-producing coun-
tries show much less progress in developing national moni-
toring systems for both antimicrobial use and AMR in
animals and the environment (Fig. 5 and Table S1). Over a
decade ago, the FAO’s consultation on ‘Antimicrobial Use
in Aquaculture and Antimicrobial Resistance’ identified
that there was a need for more national and regional data
on AMR, antimicrobial residues and antimicrobial usage,
as well as for more knowledge on the spread of AMR genes
from aquatic and fish bacteria to human pathogens (WHO,
FAO and OIE, 2006). This is still the case today, with only a
few studies having looked at AMR in the shrimp farming
industry. A summary of the published studies describing
evidence for AMR in bacteria associated with farmed
shrimp species is provided in Table S2. It is very difficult to
compare the results of the different studies due to consider-
able variation in the type of sample analysed (e.g. farmed/
Figure 4 Ways in which shrimp farming poses a potential risk to AMR dissemination for a typical integrated small-scale shrimp farm. 1. Fresh water
is sourced from local water sources and mixed with saline water, in order to reach the desired salinity. These water supplies may be polluted with
antibiotics, resistant bacteria and human/animal pathogens. 2. Human and animal waste, containing human/animal pathogens, is often used to fertil-
ize the pond to encourage the growth of algae on which the shrimp feed. 3. Unregulated use of antibiotics, which can be added directly to the pond
water and/or to the animals/humans living there. 4. Pond sediment/sludge containing antibiotics and resistant bacteria/pathogens is used as fertilizer
for chicken feed and crops, both of which are eaten by the humans. 5. Humans have direct contact with pond water, sediment/sludge and shrimp/
other animals. 6. Waste (water and sediment) is released directly back into local water sources, often untreated. 7. Shrimp (and associated bacteria/
antibiotic residues) are transported and consumed internationally.
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retail shrimp, pond water, sediment samples), the shrimp
species involved, bacterial species characterized, antibiotics
assessed and the methods used to characterize AMR. These
variations can sometimes be explained by examining the
purpose of the study: those that investigated AMR in
human pathogens associated with shrimp (commonly Vib-
rio and Aeromonas species) often tested the susceptibility to
antibiotics that are used to treat human infections, whereas
those that aimed to assess the effect of AMR on the efficacy
of the main antibiotics used in aquaculture usually tested
the susceptibility to those antibiotics. Thus, the direct com-
parison between studies is not possible due to the differ-
ences in methods and interpretative criteria deployed.
Another important issue is that 10 of the 37 studies high-
lighted in Table S2 that tested for phenotypic resistance did
not state whether they used standardized methods and
interpretative criteria for susceptibility testing (CLSI or
EUCAST, see section below on Standardization of surveil-
lance of antimicrobial usage and AMR in shrimp aquacul-
ture). Further, of those that did, many cited the standard
Shrimp Salmon
Shrimp Salmon
Shrimp Salmon
(a)
(b)
(c)
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but did not provide evidence that they had followed the
well-defined interpretative criteria. The use of standardized
methods is essential to ensure results between different
studies are properly comparable (Schwarz et al. 2010). It is
also important to avoid conflation acquired with intrinsic
resistance, since many organisms have natural low suscepti-
bility to certain classes of antibiotics. For instance, many
Vibrio are intrinsically resistant to first generation peni-
cillins (Chiou et al. 2015). A number of human pathogens
are also intrinsically resistant to colistin, and, like many of
the polymyxins, colistin binds to the surface of plastics and
does not diffuse well through agar, meaning that results
from many of the typical disc diffusion methods are mean-
ingless (World Health Organization, 2018).
Figure 5 Progress on AMR governance. Data from the WHO AMR self-assessment survey, in which a multi-sectoral group from each country is
asked to submit annual responses to a questionnaire on AMR and antimicrobial use, in order to monitor progress and identify areas for action. Data
shows country responses for the top 10 shrimp- and salmon-producing countries (year two data, 2017–2018, published on 18th July 2018) for the
topics below. Countries rate themselves from A (no action being taken; red) to E (best practice; dark green). Responses for each category are shown,
taken directly from the self-assessment survey. Black indicates no response given. Pie chart proportions indicate relative levels of production (in metric
tonnes) for each country. OIE: World Organisation for Animal Health. (a) No response (black); No national AMR action plan (red); National AMR action
plan under development (orange); National AMR action plan developed (yellow); National AMR action plan approved by government that reflects Glo-
bal Action Plan objectives, with an operational plan and monitoring arrangements (light green); National AMR action plan has funding sources identi-
fied, is being implemented and has relevant sectors involved with a defined monitoring and evaluation process in place) (dark green). (b) No response
(black); No national plan or system for monitoring sales/use of antimicrobials in animals (red); Plan agreed for monitoring quantities of antimicrobials
sold for/used in animals, based on OIE standards (orange); Data collected and reported on total quantity of antimicrobials sold for/used in animals and
their intended type of use (therapeutic or growth promotion) (yellow); On a regular basis, data is collected and reported to the OIE on the total quan-
tity of antimicrobials sold for/used in animals nationally, by antimicrobial (light green); class, by species (aquatic or terrestrial), method of administra-
tion, and by type of use (therapeutic or growth promotion) (dark green) Data on antimicrobials used under veterinary supervision in animals are
available at farm level, for individual animal species). (c) No response (black); No national plan for a system of monitoring of AMR is available (red);
National plan for monitoring AMR but capacity (including laboratory) for surveillance and reporting data on AMR is lacking (orange); Some AMR data
is collected locally but may not use a standardised approach and lacks national coordination and/or quality management (yellow); Priority pathogenic/
commensal bacterial species have been identified for surveillance (light green). Data systematically collected and reported on levels of resistance in at
least 2 of those bacterial species, involving a laboratory that follows quality management processes, e.g. proficiency testing; National system of
surveillance of AMR established for priority pathogens and for relevant commensal bacteria which follows quality assurance processes in line with
intergovernmental standards (dark green). Laboratories that report for AMR surveillance follow quality assurance processes).
Figure 6 Shrimp export rejections due to the presence of residues of prohibited antibiotics or those exceeding the maximum residual levels permit-
ted. Number of border rejections due to antibiotic residue hazards in (a) EU (data taken from EU’s Rapid Alert System for Food and Feed portal on 03/
12/2018, analysing search results from 01/01/2010 to 31/10/2018, filtering only shrimp border rejections due to antibiotic residues). India (blue); Viet-
nam (green); Bangladesh (yellow); China (red); Myanmar (purple). (b) USA (data taken from FDA’s Refusal Entry Database, from 01/01/2010 – 31/10/
2018, filtering only shrimp border rejections due to antibiotic residues. Data on total number of samples tested each year were not readily available
from either database. China (red); Malaysia (yellow); Vietnam (green); India (blue); Others (purple)
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Dissemination of resistance through shrimp farms and
hatcheries
High levels of antimicrobial resistant bacteria have been
reported in the environment local to shrimp farms (Sun-
daramanickam et al. 2015; Rocha et al. 2016), and AMR
genes have been shown to persist in the environment close
to aquaculture sites even after antibiotic usage has ceased
(Tamminen et al. 2011). This is particularly concerning
since many of the pathogens present in shrimp ponds and
hatcheries (e.g. Vibrio and Aeromonas species) are endemic
to the surrounding marine and estuarine environments,
meaning that resistant bacteria released into these environ-
ments have the potential to become the predominant
strains. This risk is compounded by the high levels of
antibiotic pollution in the environment surrounding
shrimp aquaculture facilities, with growing evidence of the
role of farms themselves in this pollution, through the
release of water and pond sediments (Akinbowale et al.
2006; Hoa et al. 2011; Hossain et al. 2017, 2018; Lai et al.
2018). Inflowing local water sources can also be heavily pol-
luted with antimicrobial compounds and resistant bacteria.
For example, in China it was reported that the AMR genes
present in shrimp farm input water correlated with that of
the pond water, both in their abundance and temporal pat-
terns (Su et al. 2017). Resistant bacteria can also enter
shrimp farms through products added to the ponds, such
as shrimp feed and probiotics. In intensive and semi-inten-
sive shrimp farming, pellet feeds containing animal- and
plant-based products are common, however their composi-
tion varies and antibiotic compounds are often added in
order to preserve the feed in hot climates. To our knowl-
edge, no studies have investigated the carriage of AMR
genes in shrimp feed, although multidrug-resistant patho-
gens have been detected in fish feed, with one study report-
ing 132 unique AMR genes and four mobile genetic
elements in five fishmeal products (Han et al. 2017;
Antunes et al. 2018; Novais et al. 2018). Extensive shrimp
farming is more commonly associated with home-made
feeds mixed with antibiotics, however one survey of Viet-
namese farmers found that many did not know the appro-
priate method of use, or dose, of the antibiotics
incorporated, and sometimes even did not know the name
of the antibiotic being used (Le & Munekage 2004). Con-
cerns have also been raised over the accuracy and quality of
the probiotics sold to shrimp (and other aquaculture)
farmers, with studies reporting bacterial content different
from those listed on the label, and carrying resistance to
multiple antimicrobials (Noor Uddin et al. 2015; Uma &
Rebecca 2018). Unconsumed feed and probiotics also con-
tribute to antibiotic-and AMR-rich waste feed and faeces
released into the local environment, where they may be
taken up by wild organisms (Thuy et al. 2011). For
example, it is thought that 95% of consumed oxytetracy-
cline is released into the surrounding environment through
faeces (Serrano 2005). Due to the high levels of untreated
waste containing antimicrobial residues and resistant bacte-
ria discharged by shrimp farming into the local environ-
ment, it is also possible that human populations living
downstream of these facilities may be directly exposed. A
recent study by Shen et al. (2018) looked at levels of Escher-
ichia coli carrying the mcr-1 gene conferring resistance to
colistin in stool samples from more than 5000 individuals
across China, and found that higher levels of mcr-1 corre-
lated with living in aquaculture-intense areas. The use of
colistin in animals is now banned in China, but used to be
orally administered to pigs and poultry and is poorly
absorbed, thus the authors suggested that these levels could
be due to faecal contamination of the aquatic environment,
where colistin is highly stable.
Given the nature of the shrimp farming environment,
many shrimp farms are at, or close to, sea level, and flood-
ing poses a huge threat to farmers’ livelihoods. It also pro-
vides a means by which resistant bacteria and antibiotic
residues present in the ponds and aquatic environment can
be disseminated over an enormous area very quickly.
Increasing global temperatures have also been suggested to
play a role in increasing AMR (MacFadden et al. 2018),
presumably due to increased temperatures favouring bacte-
rial growth. Indeed, a higher prevalence of V. para-
haemolyticus was detected in shrimp sold at Chinese
domestic markets during the summer months (Yang et al.
2017).
Another important factor contributing towards AMR
emergence and dissemination in the shrimp farming envi-
ronment is co-selection with other antimicrobials, such as
anti-fungicides, anti-parasitics and heavy metals (Seiler &
Berendonk 2012). If these are present, selection for resis-
tance genes can take place at lower antibiotic concentra-
tions (Murray et al. 2018). High levels of heavy metals,
commonly lead, cadmium, chromium, copper and zinc,
have been detected in shrimp and pond water (Seiler &
Berendonk 2012; He et al. 2016; Sarkar et al. 2016). Many
heavy metals adsorb to particulate matter and are concen-
trated in the pond bed sediments where the shrimp reside
and feed. Antibiotics are also known to persist in pond sed-
iments as when adsorbed to them they degrade more slowly
(Thuy et al. 2011). Thus, shrimp pond sediments may be a
hub for AMR emergence and dissemination, and indeed
these have been shown to contain higher levels of antibi-
otics and antibiotic-resistant bacteria than pond water (Le
& Munekage 2004; Le et al. 2005). Other sources of aqua-
culture pollution also promote the growth of micro-organ-
isms, and therefore increase the risk of AMR dissemination,
in the local environment, such as organic enrichment with
nitrates or phosphates (Anh et al. 2010).
Reviews in Aquaculture, 1–21
© 2019 The Authors. Reviews in Aquaculture Published by John Wiley & Sons Australia, Ltd10
K. Thornber et al.
One of the main direct routes for AMR dissemination to
humans in the shrimp industry is likely to be through
human contact with resistant bacteria present in the farm
environment. Compared to salmon farming, shrimp farm-
ing occurs in countries where aquaculture is labour-inten-
sive; ten times more people are employed per tonne of
production in the main shrimp-producing country (China;
78 people per 1000 tonnes) compared to the main salmon-
producing country (Norway; 6 people per 1000 tonnes;
FAO, 2016b). Thus, human exposure levels are considered
to be very high in shrimp farming, largely due to a greater
prevalence of traditional farming methods. For example,
small-scale farm workers frequently wade through ponds to
feed, assess and harvest animals, and most live in close
proximity to ponds and other animals on the farm who are
exposed to the same pathogens and AMR genes. Many
more people are also exposed through shrimp processing
and onward sale. In agricultural settings, a number of stud-
ies have now shown that humans in direct contact with ani-
mals (e.g. farm workers) have increased levels of AMR
genes and resistant bacteria associated with the farm ani-
mals and the antibiotics they were being exposed to (Mar-
shall & Levy 2011). Reports of this in aquaculture are very
limited, with one study showing that people working
within Korean aquaculture had a higher faecal carriage of
resistant bacteria than control restaurant employees (Shin
& Cho 2013), and a second identifying quinolone resistance
genes in marine bacteria in a Chilean salmon aquaculture
area that were identical to those in urinary tract E. coli
pathogens from humans living close by, suggestive of HGT
(Tomova et al. 2015). There are also bacterial infections
associated with shrimp handling, for example, fish-han-
dler’s disease, commonly caused by infection of cuts in the
skin with Mycobacterium species, which are rarely serious
but can develop into deeper tissue infection or sepsis.
Although there are no reports of resistance being a problem
in these infections, they provide a route by which resistance
genes can potentially enter the human body.
Human consumption of shrimp is another route by
which AMR genes from shrimp can be transferred into
human pathogens, since any resistant bacteria associated
with shrimp are brought into close contact with human gut
bacteria (Hoelzer et al. 2017). A number of human patho-
gens are associated with shrimp, such as Vibrio para-
haemolyicus, one of the most important causes of food-
borne bacterial infectious diarrhoea in South East Asia
(Nair et al. 2007; Li et al. 2014), and Vibrio vulnificus, a
serious human pathogen carrying a very high case fatality
rate (Jones & Oliver 2009). Resistance genes have been
detected in shrimp products destined for human consump-
tion (Table S2), with one study associating high levels of
the colistin resistance mcr-1 gene with consumption of
meat, pork, mutton and aquaculture products (Shen et al.
2018). Consumption of resistant strains of these bacteria
not only poses a threat to humans through their inability to
be treated, but also raises the levels of resistance genes in
the gut, increasing the likelihood of dissemination.
Risk mitigation strategies
In order to be effective, measures put in place aimed at lim-
iting the risks of AMR dissemination must be appropriate
for each geographical, social, political and cultural context
(World Health Organization, 2015; Kakkar et al. 2018).
There are a number of key areas that the industry as a
whole, or at least individual countries or areas within them,
could consider. As with all AMR action plans, the principal
means by which the risk of AMR dissemination in the
shrimp industry might be mitigated is through reducing
contagion and promoting the prudent use of antimicro-
bials. Indeed, controlling contagion is essential for the
shrimp industry irrespective of the risks of AMR, due to
the ever-increasing burden of disease that threatens the
future of the industry and the livelihoods of those within it.
Regulate antibiotic sales/usage
For effective prevention and better control over the use of
antimicrobial agents in aquaculture, national and interna-
tional level regulatory frameworks on the sales, use and
quality of antimicrobial agents are required. All of the top
10 shrimp-producing countries do have regulations in
place for the use of antibiotics in aquaculture, but there is a
huge disconnect between regulation and enforcement. In
an ideal world, veterinarians, or other licensed fish health
professionals, would prescribe antimicrobials, and licensing
would be enforced and guided by qualified fisheries and
animal health professionals. This is not the case in most
shrimp-producing countries, and imports to the EU and
US are regularly rejected due to testing positive for prohib-
ited antibiotic residues or residues above the maximum
residue levels (MRLs; Fig. 5). For example, between 1st
October 2014 and 30th September 2015, 32% of sampled
shrimp imports from peninsular Malaysia to the US tested
positive for chloramphenicol and/or nitrofuran residues,
antimicrobial compounds that are banned for use in food
production in Malaysia (Fig. 6). This led to the FDA
imposing an Import Alert on shrimp products from Malay-
sia in April 2016 (FDA Import Alert #16-136). Similarly,
there has recently been a growing concern within the EU
over the level of antibiotic use in the Indian shrimp farm-
ing, and, accordingly, the rate of testing has been increased
from 10 to 50 per cent (Behera 2018). However, although
export restrictions undoubtedly help to reduce antibiotic
usage, they only detect antibiotic usage immediately prior
to harvesting, and do not apply pressure to hatcheries and
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shrimp destined for domestic markets. It is also worth not-
ing that the balance of trade is shifting from a bipolar Glo-
bal South to North, to South-South trading, upsetting the
current trade-related and buyer-led forms of regulation
(Belton et al. 2018). Despite significant progress in the
development of AMR action plans, a significant barrier to
reducing antibiotic usage in the major shrimp-producing
countries is the lack of resources to implement the regula-
tions that are already in place.
Alternatives to antimicrobials
There is currently limited scope for prophylaxis through
vaccination in shrimp, due to their inability to raise an
adaptive immune response, although the increasing evi-
dence for innate immune memory may offer future possi-
bilities (Milutinovic & Kurtz 2016). Alternative options
have focussed on stimulating shrimp immunity and main-
taining a healthy shrimp and pond microbiome (a term
given to describe the suite of microorganisms in a particu-
lar environment), with pond water bacterioplankton com-
position having been suggested as a potential indicator of
shrimp health status (Zhang et al. 2014). A number of
immune stimulants are now available for use in shrimp
(Barman & Nen 2015), although there is limited data on
their effectiveness. Probiotics are widely used, and prebi-
otics have also shown some efficacy in shrimp. As an exam-
ple, Litopenaeus vannamei fed on a diet with supplementary
poly-b-hydroxybutyrate (PHB) had increased growth and
feed conversion rates, and showed improved immunity
(Duan et al. 2017). Similar positive results were seen with
PHB in Macrobrachium rosenbergii larvae (Nhan et al.
2010). Many farmers also reportedly use herbal medicines
(Chi et al. 2017), and these have been shown to exhibit
antimicrobial effects. Examples here include two essential
oils from the Madagascan plant, Cinnamosma fragrans,
which had effects similar to erythromycin in lowering bac-
terial count and increasing survival rates of Penaeus mon-
odon larvae in hatcheries (Randrianarivelo et al. 2010). The
identity of the active ingredients of many herbal remedies,
however, are unknown and some may be toxic to humans
or the environment. In addition, it is highly likely that
resistance will ultimately develop to any antimicrobial com-
pound present.
One of the most promising alternative treatment options
to replace antibiotics is phage therapy. Bacteriophages (re-
ferred to as ‘phages’) are viruses that infect and kill bacteria,
so theoretically they could be used to treat infections and
reduce levels of resistant bacteria. However, in order for
this to be effective, the infecting/resistant pathogen must be
identified, and this diagnostic capacity is not widely avail-
able in the shrimp industry. One option that has been sug-
gested for shrimp aquaculture is to target bacteria which
are known to colonize shrimp ponds and cause infections
in both shrimp and humans, for example, phages against
Vibrio harveyi have been isolated from shrimp hatcheries
and shown to increase survival of larvae. In one study,
phage therapy over a period of 17 days increased the sur-
vival of Penaeus mondon larvae from 17 to 86%, whereas
antibiotic treatment survival rates were 40% (Vinod et al.
2006). However, it must be noted that phages have also
been shown to be vectors for the dissemination of AMR
genes, since they can transfer pieces of DNA from one bac-
terial host to another (Subirats et al. 2016). Other com-
pounds specifically targeting Vibrio bacteria are also
available and could be potential treatments for shrimp Vib-
rio infections, as well as more general methods such as quo-
rum-sensing inhibitors that interfere with bacterial cell–cell
communication (Defoirdt et al. 2011).
Improved disease diagnosis
Accurate diagnosis of disease allows for the selection of
appropriate antimicrobials, and avoidance of antibiotics
critical for use in human health. This would prevent the
use of antibiotics for viral infections, but the administration
of medicines in these circumstances may in fact be reason-
able given the suite of possible pathogen interactions at any
one time. For example, WSSV infection has been shown to
increase susceptibility to other bacterial pathogens (Phuoc
et al. 2008). Yet, many shrimp-producing countries do not
have the resources to provide farmers with easy and afford-
able access to veterinary officers or diagnostic facilities, and
so farmers have no choice but to self-diagnose and self-
treat. Better diagnostic support and access would allow
farmers to receive advice not only on the best treatment,
but also on the best application method, dose and length of
treatment, all of which would help to reduce unnecessary
antimicrobial usage. In line with this, our own work with
WorldFish in Bangladesh is supporting the development of
in-country skills sets for accurate pathogen and disease
diagnosis. We are doing this through facilitating the use of
a combination of molecular (largely PCR-based methods,
but also more comprehensive sequencing approaches, e.g.
MinION sequencing) and histopathology techniques. The
associated research in this programme of work is also seek-
ing to better understand the assemblages of microorgan-
isms associated with shrimp infections and disease states –
the so-called pathobiome, as many diseases in shrimp (and
finfish) aquaculture appear to be polysyndromic in nature
and are not caused by a single pathogen (Stentiford et al.
2017 ).
Advances in next generation-sequencing technologies
have transformed human health infectious disease diagno-
sis, and offer much potential for transfer to the aquaculture
sector. Whole genome-sequencing (WGS) of bacterial
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isolates not only facilitates accurate diagnosis, but also
allows for improved monitoring of disease epidemiology,
as well as the detection and surveillance of AMR genes and
associated mobile genetic elements (Bayliss et al. 2017). In
addition, research into shrimp transcriptomics shows
potential for applications in health monitoring and the
development of immune stimulants or treatments to com-
mon infections (Rodriguez-Anaya et al. 2018). As more of
the shrimp industry moves towards selective breeding of
broodstock, these new technologies also offer much scope
for genomic-assisted selection, for example, through identi-
fication of genes encoding greater tolerance to specific
pathogens or stress (Guppy et al. 2018). With such poten-
tial impact, it is no surprise that much of the current scien-
tific research into shrimp aquaculture is focusing on the
application of these technologies, although the capacity to
implement any outcomes from this research remains lim-
ited in most shrimp-producing countries, as most laborato-
ries do not have the expertise, staffing or equipment to
conduct such studies. Laboratory capacity and expertise is
improving, however, through initiatives such as the UK
government-funded Fleming Fund (https://www.flemingf
und.org/), and technological advances such as the develop-
ment of the portable MinION sequencer (https://nanopore
tech.com/products/minion) are increasing the accessibility
of these applications to the shrimp industry. Further,
pond-side Genedrive platform PCR-based diagnostics, that
are straightforward enough for farmers to use, are also
becoming a reality, and these have recently been deployed
in commercial farm settings across regions in Thailand
(Minardi et al. 2019).
Improved hygiene and farm management
Better management practices (BMPs) for shrimp farming
are often based upon the FAO’s Code of Conduct for
Responsible Fisheries (FAO, 1995), with the aim of standar-
dising management practices. Usually, BMPs are adapted
for the various types of shrimp production (e.g. intensive/
extensive), and thereby aim to reduce the risk of disease
and environmental degradation specific to these produc-
tion systems. For example, in terms of antimicrobial usage,
large vertically integrated companies may be able to put in
place advanced biosecurity systems to limit the spread of
disease both within and between their ponds, but this rela-
tive control may be offset by higher stocking densities and
greater perceived risks relative to loss values. Both may act
as drivers for higher disease risk and greater usage of
antimicrobials. In contrast, subsistence farmers may find
control much harder to achieve. In these cases, farmers
may also be less risk averse, especially if practising polycul-
ture where losses to shrimp crop may be offset by other
products (e.g. rice, fish; Hinchliffe et al. 2018; Little et al.
2018). In all production types, proper management of the
aquaculture environment in the terms of parameters such
as feed rates, dissolved oxygen, stocking densities, move-
ment restrictions, water treatment and biological control
could go a long way in avoiding excessive use of antimicro-
bial agents. Thus, one of the routes to reducing unnecessary
antimicrobial usage is to encourage farmers to adopt BMPs.
A recent report by Suzuki & Hoang Nam 2018 reported
that in Vietnamese shrimp farming, which consists mainly
of small-scale farms, receiving training and appropriate
information increased BMP adoption, and that BMP adop-
tion reduced disease outbreaks.
Increased species diversity
A general shift in shrimp farming from Penaeus mondon to
Litopenaeus vannamei in the last decade is considered to
have helped the expansion of the industry. This is because
Litopenaeus vannamei has a higher feed conversion rate and
can tolerate a wider range of salinities, allowing inland
farming where there is lower salinity. Importantly for
antibiotic usage, it also has a higher tolerance to disease,
with higher hatchery survival rates (Kumar & Engle 2016).
Since pathogens often affect one species more than another
(e.g. Penaeus monodon is thought to be more susceptible to
WSSV than Litopenaeus vannamei; Tuyen et al. 2014), it
could be argued that the industry would benefit from a
wider variety of species, and a lower disease burden would
reduce the need for antimicrobials. Interestingly, genetically
improved species have been successfully introduced to tila-
pia farming (Kumar & Engle 2016), so there could be scope
for selected breeding of new shrimp species to reduce the
disease burden in shrimp.
Better regulation of feed and probiotic manufacture and
sales
The use of medicated feed is widespread in aquaculture.
Avoiding overuse of feed is thus a relatively straightforward
way to reduce environmental contamination with antimi-
crobial residues and resistant bacteria, since up to 30% of
feed is unconsumed (Cabello et al. 2013). Inappetence is a
typical symptom of infections in aquatic animals, so pro-
viding medicated feed can be of questionable benefit unless
very carefully managed (Ranjan et al. 2017). Regulations
on feed used in aquaculture are in place in some countries,
for example the Vietnamese National Fisheries Quality
Assurance and Veterinary Directorate (NAVIQAVED)
attempts to test and control feed quality across the indus-
try. However, the large number of feeds available on the
market makes this very difficult, with more than 100 types
of feed produced domestically and many more imported
from across the world (Anh et al. 2010).
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Probiotics are now widely used in shrimp aquaculture to
stimulate immunity and improve feed digestion and water
quality, despite scepticism from the scientific community
over their efficacy. A few studies have suggested that
administration of probiotics to Litopenaeus vannamei post-
larvae can improve growth and feed efficiency, increase
expression of immune related genes and even protect
against infection by WSSV (Chai et al. 2016; Miandare
et al. 2016). However, reports identifying discrepancies in
probiotic contents and labelling, and the presence of resis-
tant bacteria, show the need for better regulation of their
contents and improvements in the information provided
for the farmer on their specific purpose, dosage and correct
application measures (Noor Uddin et al. 2015). Thus, as
for medicated feed, avoiding excess use of probiotics is nec-
essary to reduce any risk of contamination with unknown
and potentially resistant bacteria.
Farmer education
Many of the major shrimp-producing countries offer a
range of courses on aquaculture management for farmers to
attend, ranging from government/non-governmental
organisation workshops to university degrees. However,
surveys conducted on farmers’ knowledge of antibiotic use
have suggested that they have a limited understanding about
the purpose of antibiotics, their appropriate use, dose and
method of application (Holmstrom et al. 2003; Mostafa
Shamsuzzaman & Kumar Biswas 2012; Pham et al. 2015).
For example, one survey of Vietnamese farmers found that,
despite 45% of respondents believing that antibiotics had no
effect, 86% still used them, and 12 of the 23 antibiotics being
used were listed as critically important by the WHO (Pham
et al. 2015). In a separate study, 27% of Thai shrimp farmers
surveyed were using antibiotics to treat viral diseases such as
white spot syndrome (Holmstrom et al. 2003). In line with
these reports, the WHO AMR self-assessment survey found
that training and professional education on AMR in the
farming sector was very poor in the top 10 shrimp farming
countries, although the high-income salmon farming coun-
tries had much to improve on too (Table S1).
Certification
Aquaculture certification and labelling programmes have
become the primary tool to address sustainability issues in
farmed seafood, which includes promoting prudent antimi-
crobial usage. Such schemes are already in place, with the
majority of all certified aquaculture production covered
through the Aquaculture Stewardship Council (ASC), Glo-
bal Aquaculture Alliance Best Aquaculture Practice (GAA-
BAP), Global G.A.P. and Friend of the Sea. To increase
audit efficiency and reduce farmer administrative
workload, the three leading aquaculture certification pro-
grammes, ASC, GAABAP and Global G.A.P. have now
drafted and agreed combined checklists for farms that seek
more than one certificate, however the growth in the num-
ber of certification schemes has increased confusion. As a
result, the Global Sustainable Seafood Initiative (GSSI) has
been created, tasked with developing a global benchmark-
ing tool to measure and compare certification schemes and
standards performance. Despite this progress on certifica-
tion, one of its main disadvantages is that it is largely
focused on the export market, and has limited influence on
the production of shrimp destined for the domestic market
and hatcheries, where certification is less valued. Further,
the costs associated with becoming certified, and the
requirement for book keeping and auditing, are more
accessible to larger farms, whereas the majority of shrimp
farmers, in many countries, are family-run smallholders.
Standardization of surveillance of antimicrobial usage and
AMR in shrimp aquaculture
Over a decade ago, the WHO/FAO/OIE’s consultation on
‘Antimicrobial Use in Aquaculture and Antimicrobial
Resistance’ identified that there was a need for both more
national and regional data on AMR, antimicrobial residues
and antimicrobial usage, as well as for more knowledge on
the spread of AMR genes from aquatic and fish bacteria to
human pathogens (World Health Organization, Food and
Agriculture Organization of the United Nations and World
Organization for Animal Health, 2006). Improved surveil-
lance has been identified as key to reducing antimicrobial
usage across all human and animal health sectors, and is an
integral part of national AMR action plans. Surveillance of
antimicrobial usage and resistance would cover the entire
shrimp industry and would not be restricted to products
destined for export. However, like most LMICs, the main
shrimp-producing countries are still at a very early stage in
the development of any type of AMR/AMU surveillance
system (Fig. 5), and effective surveillance will be very diffi-
cult to achieve without first gaining tighter control of
antibiotic sales.
Standardization of the methods used to both measure
sensitivity to antibiotics and then interpret the resultant
antimicrobial sensitivity testing (AST) data (Alderman &
Smith 2001; World Organization for Animal Health, 2018)
is also crucial. It is strongly recommended that Clinical and
Laboratory Standards Institutes (CLSI; or other equivalent
international standards, e.g. EUCAST) are used for this type
of testing. It is also very important that appropriate quality
assurance processes are in place to ensure the integrity of
AST data. For bacteria isolated from aquatic animals, the
creation of CLSI standards for antimicrobial disk diffusion
testing and determination of minimal inhibitory
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concentrations by broth micro- and microdilution are
important steps in this process (CLSI, 2006, 2014a,2014b).
It is recognized that further work is required here to develop
these provisional standards, particularly with the types of
pathogens that affect tropical species such as shrimp.
There are major efforts underway (e.g. via the UK
Government-funded Fleming Fund) to support LMICs to
improve their laboratory capacity for the surveillance of
AMR and antibiotic usage. Although most of this will
understandably be used to improve surveillance in clinical
settings, it is also recognized that this should encompass
animal (including aquaculture) production in these coun-
tries. As an example, the Fleming Fund and UK Govern-
ment have recently provided funding to support the
development of a new Food and Agriculture Organisation
of the United Nations (FAO) designated International Ref-
erence Centre for AMR, run through the UK agencies of
the Department for Environment, Food and Rural Affairs -
Veterinary Medicines Directorate (VMD), Centre for Envi-
ronment Fisheries and Aquaculture Science (CEFAS) and
the Animal and Plant Health Agency (APHA). The centre
will seek to improve the balance of the one-health approach
and take the steps needed to improve AMR surveillance in
the animal and environmental sectors. Specifically, the cen-
tre will provide technical assistance, training and quality
assurance to support an increase in AMR surveillance in
low- and middle-income countries across Asia and Africa.
Conclusions
There is a growing movement to reduce the use of antimi-
crobials in food animals in general, but many of the practi-
cal solutions put forward, such as increasing the price of
antibiotics and capping the amount used per animal, rely
on governments having the means to implement and
enforce regulations and assess their efficacy, which is not
the case in most shrimp-producing countries (Van Boeckel
et al. 2017). One of the main barriers to better regulation is
that the Competent Authorities responsible for their imple-
mentation in many shrimp-producing countries are very
understaffed and under resourced. As a result, there is often
a paucity of officials compared to the number of farms, and
a lack of the knowledge required for accurate diagnosis of
the disease conditions. This makes long term programmes
(e.g. surveillance) difficult to implement and become effec-
tive. To this end, a phased approach to creating the surveil-
lance networks required for LMIC governments to
effectively achieve reductions in inappropriate antimicro-
bial usage has recently been suggested (Schar et al. 2018).
Another barrier to effective antibiotic sales and usage regu-
lation and surveillance in many shrimp-producing coun-
tries is the informal medicines supply network, in which
the sale of substandard and counterfeit antibiotics is a
problem (Zellweger et al. 2017). It is unrealistic, and unfair,
to expect farmers in LMICs to reduce antibiotic usage with-
out major investments in farm hygiene, biosecurity and
associated diagnostic/veterinary services (UN Interagency
Coordination Group on Antimicrobial Resistance, 2019).
In many shrimp-producing countries, the majority of diag-
nostic and prescriptive services are provided by a largely
untrained and unregulated paraveterinary sector, since
there are simply not enough trained veterinary officers
(Hinchliffe 2019).
Thus, the infrastructure for the central control of the reg-
ulatory, diagnostic and surveillance systems does not exist
or is insufficient in many shrimp-producing countries.
Adopting as models the systems that work in high income
countries may not be practical in the timescales that are
required to reduce the global burden of AMR (Cox et al.
2017). Solutions could therefore look towards more self-
regulatory processes. This could include a greater involve-
ment of extension officers, such as those employed by
WorldFish and other international non-governmental
organisations, for delivering training and educational pro-
grammes (https://www.worldfishcenter.org/). Raising
farmer awareness of better management practices should
also improve farm hygiene and biosecurity, thereby reduc-
ing contagion and AMR dissemination. More generally,
increased community awareness of AMR and the risks of
antibiotic misuse could promote a degree of self-policing,
of both farmers and the local antibiotic suppliers, which in
shrimp farming communities are often untrained local farm
shop owners (Hinchliffe 2019). Aquaculture could usefully
learn from the human health sector, which is facing the
same issues in LMICs in terms of lack of resources for regu-
lation and surveillance of antibiotic sales and usage. In some
LMICs, antibiotic stewardship programmes in the human
drug sector have been focusing on the drug suppliers, for
example the accredited drug dispensing outlet (ADDO)
programme, which began in Tanzania and has now been
extended to other African countries and Bangladesh (Rutta
et al. 2015). This programme of accreditation for local drug
shops, which includes training and signing up to codes of
conduct, has seen significant improvements in dispensing
practices, although it has been noted that future efforts
should also include public engagement, in order to reduce
public demand for these drugs (Embrey et al. 2016).
Since AMR and inappropriate antibiotic use are true
‘One Health’ issues, that do not respect differences in
human/animal sector boundaries, it seems sensible that
these sectors both learn from and work with each other, in
order to effect maximal understanding and impact. In the
context of AMR, local actions have international conse-
quences, thus national governments, international agen-
cies/organisations and the private sector need to co-
ordinate their efforts, knowledge and resources if we are to
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reduce the risk that the shrimp industry poses to global
AMR dissemination. This review has highlighted some of
the socioeconomic, political and cultural aspects of this
risk, and has outlined some of the major challenges that
must be overcome in order to mitigate it. In doing so, we
have demonstrated the paucity of information available on
the use of antimicrobials, the prevalence of AMR in shrimp
and human pathogens, as well as on the types of resistance
mechanisms carried by these species in shrimp aquaculture.
As a result, it is currently very difficult to accurately assess
the risks posed by the use of antimicrobials in this rapidly
growing sector, which includes a wide range of production
systems at the interface between the aquatic and terrestrial
environments. Given the complexity of the shrimp aqua-
culture environment in terms of potential sources of AMR
genes and antibiotic residues, and the means by which these
are disseminated, it is therefore vital to gather more avail-
able data on AMR and antibiotic sales/usage in shrimp
aquaculture in order to establish where future efforts aim-
ing to reduce this are best placed. Equally important, how-
ever, is the need for wider public engagement and a better
understanding of the social, economic and political limita-
tions to achieving these goals in each country. A co-ordi-
nated approach, between experts in the aquaculture,
clinical, environmental and social disciplines, from both
the private and public sectors, will be essential.
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